Scientific Communication & EducationbioRxiv
Delivering on the Vision of Bench to Bedside: A Rare Disease Funding Community Collaboration to Develop Effective Therapies for Neurofibromatosis Type 1 Tumors
S. La Rosa, V. Browder, A. C. Bakker…·N. Bora
The paper analyzes funding efforts by four organizations to accelerate MEK inhibitor development for NF1-associated tumors.
DOI 10.15252/emmm.201911656